Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Minoxidil

This article was originally published in The Tan Sheet

Executive Summary

ANDAs for minoxidil topical solution 5% submitted by Alpharma (75-518) and Copley Pharmaceuticals (75-619) were approved by FDA Nov. 17; Pharmacia's Rogaine Extra Strength for Men lost market exclusivity Nov. 14. Alpharma, which debuted its generic version of the hair regrowth treatment at the Private Label Manufacturers Association annual trade show in Chicago Nov. 13-14, began shipping the product Nov. 18. The 60 mL bottles will be sold in single-, double- and triple-packs and will retail for between $14.99 and $19.99 per bottle, the company says. Perrigo also plans to offer a generic version of minoxidil 5%, but was forced to push back the shipping date until April due to an unfavorable FDA inspection of its Allegan, Mich. facility (1"The Tan Sheet" Oct. 30, p. 13)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS091939

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel